Over 520 HIV drugs in pipeline with high approval likelihood

Summary: GlobalData reports over 520 active pipeline drugs for HIV/AIDS, with a 95.74% likelihood of approval. HIV weakens the immune system, leading to AIDS, a global health concern. Antiretroviral therapy has transformed HIV into a manageable chronic condition, but access to treatment varies. Stigma and discrimination hinder prevention efforts. Comprehensive strategies including education and treatment access are crucial. Ongoing research and community support are vital to end the pandemic.

Full article